Malignant bone tumor | Benign bone tumor | |||
---|---|---|---|---|
Demographic features | Groups | Osteosarcoma (N = 30) | Ewing Sarcoma (N = 30) | GCT (N = 30) |
Age | 30 | 11(36.6%) | 20(66.7%) | 16(53.3%) |
30 | 19(63.3%) | 10(33.3%) | 14(46.7%) | |
Gender | Male | 16(53.3%) | 12(40%) | 17(56.7%) |
Female | 14(46.7%) | 18(60%) | 13(43.3%) | |
Tumor size (cm) | 10 | 16(53.3%) | 18(60%) | 26(86.7%) |
10 | 14(46.7%) | 12(40%) | 4(13.3%) | |
Tumor grade | Low (grade I/II) | 11(36.7%) | 10(33.3%) | 30(100%) |
High (grade III) | 19(63.3%) | 20(66.7%) | 0(0%) | |
History of particular disease | Positive | 7(23.3%) | 4(13.3%) | 4(13.3%) |
Negative | 23(76.7%) | 26(86.7%) | 26(86.7%) | |
Chemotherapy | Positive | 17(56.7%) | 17(56.7%) | 0 |
Negative | 13(43.3%) | 13(43.3%) | 30(100%) | |
Metastasis | Yes | 9(30%) | 9(30%) | 0 |
No | 21(70%) | 21(70%) | 30(100%) | |
Tumor recurrence | Yes | 8(26.7%) | 7(23.3%) | 0 |
No | 22(73.3%) | 23(76.7%) | v |